人淋巴细胞对链球菌制剂OK-432及其组分的增殖反应。

Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions.

作者信息

Tanaka T, Kaneko Y, Haba F, Katsuta S, Tsutsui K, Tamaki S, Chen D R, Suzuki S, Ueda R, Yamamoto A

机构信息

3rd Department of Internal Medicine, Mie University School of Medicine, Tsu, Japan.

出版信息

J Clin Lab Immunol. 1989 Feb;28(2):91-6.

Abstract

This study was undertaken to examine the blastogenic responses of PBL to Streptococcal preparation OK-432 and its fractions. The results showed that OK-432 and its fractions, Su-PR and PM, have the mitogenic activity against human lymphocytes. The demonstration that PBL which had been cultured with OK-432 expressed IL-2 receptors and the blastogenic responses of PBL to OK-432 were inhibited by anti-IL-2 antibody suggested that IL-2 and IL-2 receptors might play a central role in OK-432-induced proliferation of human lymphocytes.

摘要

本研究旨在检测外周血淋巴细胞（PBL）对链球菌制剂OK-432及其组分的增殖反应。结果显示，OK-432及其组分Su-PR和PM对人淋巴细胞具有促有丝分裂活性。用OK-432培养的PBL表达白细胞介素-2（IL-2）受体，且抗IL-2抗体可抑制PBL对OK-432的增殖反应，这表明IL-2和IL-2受体可能在OK-432诱导的人淋巴细胞增殖中起核心作用。

相似文献

1

Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions.人淋巴细胞对链球菌制剂OK-432及其组分的增殖反应。

J Clin Lab Immunol. 1989 Feb;28(2):91-6.

2

In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.一种链球菌制剂OK-432对人自然杀伤细胞活性的体外增强作用：干扰素和白细胞介素-2参与OK-432的刺激过程。

J Natl Cancer Inst. 1982 Oct;69(4):807-12.

3

Interleukin-1 inducing activity of a streptococcal preparation OK-432 and its fractions by human monocytes.链球菌制剂OK-432及其组分对人单核细胞的白细胞介素-1诱导活性。

J Clin Lab Immunol. 1989 Mar;28(3):129-36.

4

[Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].OK-432（沙培林）口服给药。（第8份报告）临床应用：对胃肠道癌症患者的免疫调节作用

Nihon Gan Chiryo Gakkai Shi. 1989 Aug 20;24(8):1607-15.

5

Mechanism of tumoricidal activity of OK-432-specific L3T4+ Lyt2- T-cells.

Cancer Res. 1990 Aug 1;50(15):4630-4.

6

Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparation.生物反应调节剂对复发性胃癌胸导管淋巴细胞的影响。溶血性链球菌制剂OK-432的评估。

Tokai J Exp Clin Med. 1987 May;12(2):97-102.

7

Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro.OK-432介导白细胞介素1、白细胞介素2和γ干扰素的体外产生从而生成活化的杀伤样细胞。

Jpn J Exp Med. 1987 Dec;57(6):333-8.

8

Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.使用以迟发型超敏反应（DTH）为导向剂量的链球菌制剂OK-432对胃癌恶性腹水进行局部区域免疫治疗：治疗腹水中的Th1功能障碍。

Int J Oncol. 2004 Apr;24(4):959-66.

9

[Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].[通过淋巴细胞增殖试验对链球菌制剂OK-432的各种给药途径的体内效果进行评估]

Gan To Kagaku Ryoho. 1986 Jan;13(1):95-100.

10

[A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].[一项通过免疫学参数评估口服溶链菌制剂（沙培林）的最佳剂量及其给药频率的双盲研究（第二篇报告）]

Nihon Gan Chiryo Gakkai Shi. 1990 May 20;25(5):997-1012.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。